OyaGen
Rochester
About OyaGen
OyaGen, Inc., a biotechnology company, engages in discovering, developing, and commercializing novel pharmaceutical therapies that seek to exploit RNA editing and DNA editing enzymes. Its platform technology encompasses on study of editing enzymes to affect various functions, including antiviral, cancer, immunoglobulin gene rearrangements, inflammation, ion channel function, LDL reduction, neuro-cognitive functions, and red blood cell expression in fetal liver. OyaGen, Inc. was founded in 2003 and is based in Rochester, New York.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $5.9M
- Funding stage: Early Stage Venture
- Last round: Grant (Sep 2013)
- Website: oyageninc.com
- Phone: 5852756007
Industries & Categories
Biotechnology, Genetics, Health Care
Social Profiles
Canonical: https://fsome.com/organization/oyagen-2857774 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.